Novo Nordisk Shares Slide After $2.1 Billion Vivtex Partnership and GLP-1 Price Cut Announcement on Feb. 25 | MarketWire

Novo Nordisk stock falls as it teams with Vivtex on oral obesity drugs and announces GLP-1 price cuts.